Supply Chain Ecosystem Analysis now part of DBMR Reports
Market Size in USD Billion
| 2026 –2033 | |
|
|
USD 147.70 Million |
| USD 281.58 Million | |
| % | |
|
Global Laparoscopic Power Morcellators Market Segmentation, By Application (Hysterectomy, Myomectomy and Others), End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centres and Others)- Industry Trends and Forecast to 2033
The global Laparoscopic Power Morcellators market was valued at USD 147.70 Million in 2025 and is projected to reach USD 281.58 Million by 2033, growing at a CAGR of 8.40% from 2026 to 2033. The Laparoscopic Power Morcellators market is experiencing consistent growth driven by rising prevalence of uterine fibroids, increasing demand for minimally invasive gynecological surgeries, and rapid advancements in laparoscopic surgical technologies. The growing preference for minimally invasive procedures among both patients and surgeons is further accelerating the adoption of power morcellators due to benefits such as reduced blood loss, shorter hospital stays, and faster recovery times.
The increasing burden of gynecological disorders, combined with rising healthcare awareness and expanding access to advanced surgical care in both developed and emerging economies, is compelling hospitals, ambulatory surgical centers, and specialty clinics to adopt laparoscopic procedures. In addition, continuous improvements in containment systems and safety-enhanced morcellation techniques are addressing prior clinical concerns, leading to renewed adoption across healthcare facilities globally.
Key Market Trends & Insights
Market Size & Forecast
Get Exclusive Sample Copy of this Report Here
|
Attributes
|
Laparoscopic Power Morcellators Key Market Insights
|
|
Segments Covered
|
|
|
Countries Covered
|
North America
· U.S.
· Canada
· Mexico
Europe
· Germany
· France
· U.K.
· Netherlands
· Switzerland
· Belgium
· Russia
· Italy
· Spain
· Turkey
· Rest of Europe
Asia-Pacific
· China
· Japan
· India
· South Korea
· Singapore
· Malaysia
· Australia
· Thailand
· Indonesia
· Philippines
· Rest of Asia-Pacific
Middle East and Africa
· Saudi Arabia
· U.A.E.
· South Africa
· Egypt
· Israel
· Rest of Middle East and Africa
South America
· Brazil
· Argentina
· Rest of South America
|
|
Key Market Players
|
• Johnson & Johnson (U.S.) • KARL STORZ SE & Co. KG (Germany) • Medtronic plc (Ireland) • Olympus Corporation (Japan) • Boston Scientific Corporation (U.S.) • CONMED Corporation (U.S.) • Stryker Corporation (U.S.) • B. Braun Melsungen AG (Germany) • SonoScape Medical Corp. (China) • Richard Wolf GmbH (Germany) • Hologic, Inc. (U.S.) • Stryker Endoscopy (U.S.) • Cook Medical (U.S.) • Applied Medical Resources Corporation (U.S.) • Teleflex Incorporated (U.S.) • Smith & Nephew plc (UK) • Microline Surgical (U.S.) • LiNA Medical ApS (Denmark) • Mediflex Surgical Products (U.S.) • EndoMed Systems GmbH (Germany) • Aesculap, Inc. (Germany/U.S. subsidiary of B. Braun) • CooperSurgical Inc. (U.S.) • Alltion (Wuzhou) Co., Ltd. (China) • STERIS plc (U.S.) • DTR Medical (UK) • Sunmed (U.S.) • Genicon, Inc. (U.S.) • Unimax Medical Systems Inc. (Taiwan) • Medtronic Surgical Technologies (U.S.)
|
|
Market Opportunities
|
· Expansion of Minimally Invasive Gynecological Surgeries
· Technological Advancements in Containment and Safety Systems
· Growth in Emerging Healthcare Markets
|
|
Value Added Data Infosets
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include in-depth expert analysis, geographically represented company-wise production and capacity, network layouts of distributors and partners, detailed and updated price trend analysis and deficit analysis of supply chain and demand.
|
Trend: Rising Adoption of Advanced Laparoscopic and Containment-Assisted Morcellation Techniques
Minimally invasive gynecological surgeries are increasingly shifting toward laparoscopic power morcellation with advanced containment systems to improve surgical safety and reduce tissue dissemination risks. Hospitals and ambulatory surgical centers are adopting contained morcellation techniques in procedures such as hysterectomy and myomectomy, particularly for uterine fibroids. For instance, following regulatory emphasis from the U.S. FDA on tissue containment during morcellation, adoption of in-bag morcellation systems has increased across advanced surgical centers in North America and Europe. The integration of improved laparoscopic visualization systems and energy-based surgical tools is further enhancing procedural accuracy and reducing operative complications, supporting wider clinical acceptance globally.
Key Market Driver: Rising Prevalence of Uterine Fibroids and Expanding Adoption of Minimally Invasive Gynecological Surgery
The increasing global incidence of uterine fibroids, endometriosis, and abnormal uterine bleeding is significantly driving demand for laparoscopic power morcellators. According to clinical estimates, uterine fibroids affect up to 70–80% of women by age 50, with a substantial proportion requiring surgical intervention. This has led to a growing preference for minimally invasive procedures such as laparoscopic hysterectomy and myomectomy, where morcellators are widely used for tissue fragmentation and removal. Hospitals are increasingly investing in advanced laparoscopic systems to reduce patient recovery time, minimize surgical trauma, and lower healthcare costs. Expanding healthcare infrastructure and rising gynecological surgery volumes across both developed and emerging economies are further accelerating market growth.
Key Restraint/Challenge: Regulatory Concerns and Safety Risks Associated with Tissue Dissemination
A major challenge in the global laparoscopic power morcellators market is the regulatory scrutiny related to the potential spread of undiagnosed malignant tissue during morcellation procedures. For instance, the U.S. FDA issued safety communications restricting uncontained power morcellation in uterine fibroid surgeries due to the risk of spreading unsuspected sarcomas. This has led to increased adoption of alternative surgical approaches and containment-based systems, but also temporarily slowed device utilization in some regions. In addition, the need for specialized surgical expertise and high-cost containment technologies increases procedural complexity and limits adoption in resource-constrained healthcare settings.
Key Market Opportunity: Integration of AI and Autonomous Vehicle Validation Platforms
The development of advanced containment bag systems and integration of robotic-assisted surgical platforms present significant growth opportunities for the laparoscopic power morcellators market. Contained morcellation techniques are increasingly being adopted to enhance procedural safety and comply with regulatory guidelines, especially in high-volume surgical centers. In addition, the rise of robotic-assisted gynecological surgeries—such as robotic hysterectomy and robotic myomectomy—is improving precision, reducing surgeon fatigue, and expanding minimally invasive surgery adoption. Growing investments in women’s healthcare infrastructure across Asia-Pacific and Latin America, along with increasing awareness of early diagnosis and treatment of gynecological disorders, are expected to further support market expansion globally.
The Global Laparoscopic Power Morcellators market is segmented on the basis of Application and End User.
By Application
On the basis of application, the global Laparoscopic Power Morcellators market is segmented into hysterectomy, myomectomy, and others. The Hysterectomy segment dominated the market with a 46.82% share in 2025, owing to the high prevalence of uterine fibroids, abnormal uterine bleeding, and other gynecological disorders requiring uterus removal. Increasing preference for minimally invasive surgical procedures is significantly supporting demand for laparoscopic morcellation. Rising aging female population and higher incidence of gynecological diseases are boosting procedure volumes globally. Advancements in laparoscopic surgical instruments are enhancing procedural safety and precision. Growing adoption of minimally invasive gynecological surgeries in hospitals is further strengthening market dominance. Increasing awareness among patients regarding faster recovery and reduced complications is accelerating adoption. Expansion of healthcare infrastructure in emerging economies is improving access to surgical procedures. Rising healthcare expenditure and insurance coverage are supporting surgical uptake. Continuous technological improvements in morcellation devices are improving clinical outcomes. Surgeons’ preference for minimally invasive approaches is further boosting segment growth.
The Myomectomy segment is expected to witness the fastest growth at a CAGR of 6.8% from 2026 to 2033, driven by increasing prevalence of uterine fibroids among women of reproductive age and rising demand for fertility-preserving surgical procedures. Growing awareness about minimally invasive treatment options is further accelerating adoption. Expanding access to advanced gynecological care in emerging markets is supporting procedure growth. Increasing hospital investments in laparoscopic technologies is enhancing surgical capabilities. Rising preference for uterus-preserving surgeries among younger patients is boosting demand. Continuous improvements in morcellation safety and precision are encouraging clinical adoption. Growing healthcare infrastructure development in Asia-Pacific is further supporting expansion. Rising outpatient surgical procedures are increasing utilization of laparoscopic systems. Favorable reimbursement policies in developed regions are driving procedural uptake. Increasing training of surgeons in minimally invasive techniques is further accelerating segment growth.
By End User
On the basis of end user, the global Laparoscopic Power Morcellators market is segmented into hospitals, specialty clinics, ambulatory surgical centres, and others. The Hospitals segment dominated the market with a 52.37% share in 2025, owing to availability of advanced surgical infrastructure, skilled healthcare professionals, and high patient inflow for complex gynecological procedures. Hospitals serve as the primary centers for minimally invasive surgeries due to strong access to advanced operating rooms and post-operative care facilities. Increasing investment in modern surgical technologies is strengthening hospital dominance. Rising number of gynecological procedures performed in tertiary care hospitals is contributing significantly to market share. Growing adoption of minimally invasive surgeries in hospital settings is further enhancing procedural volume. Strong reimbursement systems in developed economies are supporting hospital-based surgical adoption. Expansion of multispecialty hospitals in emerging regions is improving access to advanced surgical care. Integration of laparoscopic and imaging technologies in hospital environments is enhancing procedural accuracy. Increasing training programs for surgeons within hospitals is boosting adoption rates. Continuous technological upgrades in hospital surgical departments are further strengthening this segment.
The Ambulatory Surgical Centres segment is expected to witness the fastest growth at a CAGR of 7.1% from 2026 to 2033, driven by rising demand for cost-effective, minimally invasive, and same-day surgical procedures. Increasing patient preference for shorter hospital stays and faster recovery is accelerating adoption. Growing number of outpatient gynecological surgeries is boosting demand for ASCs. Expansion of specialized surgical centers in urban regions is supporting market growth. Lower procedural costs compared to hospitals are attracting patients to ASCs. Advancements in portable laparoscopic equipment are enabling adoption in outpatient settings. Rising healthcare infrastructure investments in emerging economies are expanding ASC networks. Increasing physician preference for efficient surgical workflows is further driving utilization. Growing insurance coverage for outpatient procedures is supporting demand. Continuous improvements in surgical safety and efficiency in ASCs are accelerating segment growth.
North America dominated the global Laparoscopic Power Morcellators market with the largest revenue share of 38.12% in 2025, supported by advanced healthcare infrastructure, high adoption of minimally invasive gynecological surgeries, and strong presence of leading medical device manufacturers. The region benefits from widespread availability of robotic-assisted surgical systems, favorable reimbursement policies, and high awareness regarding early diagnosis and treatment of uterine fibroids and other gynecological disorders. In addition, increasing preference for minimally invasive procedures and continuous technological advancements in laparoscopic surgery tools are further strengthening market growth across the United States and Canada.
U.S. Laparoscopic Power Morcellators Market Insight
The U.S. Laparoscopic Power Morcellators market is witnessing steady growth due to rising incidence of uterine fibroids, increasing hysterectomy and myomectomy procedures, and strong adoption of minimally invasive surgical techniques. The country’s advanced hospital infrastructure and high penetration of laparoscopic and robotic-assisted surgical systems are driving demand for power morcellators. In addition, continuous innovation by leading medical device companies and strong clinical research activities are further supporting market expansion.
Europe Laparoscopic Power Morcellators Market Insight
The Europe Laparoscopic Power Morcellators market remains a key regional contributor, driven by strong regulatory frameworks, well-established healthcare systems, and increasing preference for minimally invasive gynecological surgeries. Rising cases of fibroids and endometriosis, combined with growing adoption of laparoscopic techniques in hospitals and specialty clinics, are supporting market growth. Furthermore, increasing investments in surgical innovation and training programs are enhancing procedural efficiency and adoption across major European countries.
U.K. Laparoscopic Power Morcellators Market Insight
The U.K. Laparoscopic Power Morcellators market is experiencing moderate but steady growth, supported by increasing adoption of minimally invasive surgical procedures and strong presence of advanced healthcare facilities under the NHS system. Growing awareness regarding early treatment of gynecological conditions and increasing use of laparoscopic techniques in gynecology departments are driving demand. In addition, improvements in surgical training and access to advanced medical devices are further supporting market expansion.
Germany Laparoscopic Power Morcellators Market Insight
The Germany Laparoscopic Power Morcellators market is expanding due to strong healthcare infrastructure, high surgical volumes, and advanced adoption of minimally invasive procedures. German hospitals and specialty clinics are increasingly using laparoscopic tools for hysterectomy and myomectomy procedures. In addition, strong focus on surgical precision, medical technology innovation, and physician training is further driving adoption of advanced morcellation systems.
Asia-Pacific Laparoscopic Power Morcellators Market Insight
The Asia-Pacific Laparoscopic Power Morcellators market is expected to witness the fastest growth at a CAGR of 8.15% from 2026 to 2033, fueled by expanding healthcare infrastructure, rising gynecological disorder cases, increasing healthcare expenditure, and growing adoption in China, India, and Japan. Rapid urbanization, improving access to advanced surgical care, and growing awareness of minimally invasive procedures are further accelerating market expansion across the region.
Japan Laparoscopic Power Morcellators Market Insight
The Japan Laparoscopic Power Morcellators market is growing steadily due to advanced healthcare systems, high adoption of minimally invasive gynecological procedures, and strong focus on precision surgery. The country’s aging female population and increasing incidence of uterine fibroids are supporting demand. In addition, continuous technological advancements in laparoscopic surgical devices are enhancing procedural outcomes.
China Laparoscopic Power Morcellators Market Insight
The China Laparoscopic Power Morcellators market is expanding rapidly, driven by increasing healthcare investments, rising prevalence of gynecological disorders, and growing adoption of minimally invasive surgeries. Expanding hospital infrastructure, improving surgical capabilities, and government initiatives to enhance women’s healthcare are further boosting market growth. In addition, increasing availability of advanced medical devices in urban hospitals is strengthening adoption.
The Laparoscopic Power Morcellators industry is primarily led by well-established companies, including:
SKU-
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.